Rapid Diagnosis of CMT1A Duplications and HNPP Deletions by Multiplex Microsatellite PCR

  • Choi, Byung-Ok (Department of Neurology and Ewha Medical Research Center, Ewha Womans University College of Medicine) ;
  • Kim, Joonki (Department of Biological Science, Kongju National University) ;
  • Lee, Kyung Lyong (Department of Biological Science, Kongju National University) ;
  • Yu, Jin Seok (Department of Biological Science, Kongju National University) ;
  • Hwang, Jung Hee (Department of Biological Science, Kongju National University) ;
  • Chung, Ki Wha (Department of Biological Science, Kongju National University)
  • Received : 2006.10.02
  • Accepted : 2006.12.06
  • Published : 2007.02.28


Charcot-Marie-Tooth (CMT) disease and hereditary neuropathy with liability to pressure palsies (HNPP) are frequent forms of genetically heterogeneous peripheral neuropathies. Reciprocal unequal crossover between flanking CMT1A-REPs on chromosome 17p11.2-p12 is a major cause of CMT type 1A (CMT1A) and HNPP. The importance of a sensitive and rapid method for identifying the CMT1A duplication and HNPP deletion is being emphasized. In the present study, we established a molecular diagnostic method for the CMT1A duplication and HNPP deletion based on hexaplex PCR of 6 microsatellite markers (D17S921, D17S9B, D17S9A, D17S918, D17S4A and D17S2230). The method is highly time-, cost- and sample-saving because the six markers are amplified by a single PCR reaction and resolved with a single capillary in 3 h. Several statistical and forensic estimates indicated that most of these markers are likely to be useful for diagnosing the peripheral neuropathies. Reproducibility, as determined by concordance between independent tests, was estimated to be 100%. The likelihood that genotypes of all six markers are homozygous in randomly selected individuals was calculated to be $1.6{\times}10^{-4}$, which indicates that the statistical error rate for this diagnosis of HNPP deletion is only 0.016%.


Charcot-Marie-Tooth Disease (CMT);CMT1A;Hereditary Neuropathy with Liability to Pressure Palsied (HNPP);Hexaplex PCR;Microsatellite;PMP22


Supported by : Korea Research Foundation, Ministry of Health and Welfare in Korea


  1. Chance, P. F., Abbas, N., Lensch, M. W., Pentao, L., Roa, B. B., et al. (1994) Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum. Mol. Genet. 3, 223−228
  2. Jordanova, A., Thomas, F. P., Guergueltcheva, V., Tournev, I., Gondim, F. A., et al. (2003) Dominant intermediate Charcot- Marie-Tooth type C maps to chromosome 1p34-p35. Am. J. Hum. Genet. 73, 1423−1430
  3. Lopes, J., Ravisé, N., Vandenberghe, A., Palau, F., Ionasescu, V., et al. (1998) Fine mapping of de novo CMT1A and HNPP rearrangements within CMT1A-REPs evidences two distinct sex-dependent mechanisms and candidate sequences involved in recombination. Hum. Mol. Genet. 7, 141−148
  4. Nelis, E., Van Broeckhoven, C., De Jonghe, P., Lofgren, A., Vandenberghe, A., et al. (1996) Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur. J. Hum. Genet. 4, 25−33
  5. Passage, E., Norreel, J. C., Noack-Fraissignes, P., Sanguedolce, V., Pizant, J., et al. (2004) Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med. 10, 396−401
  6. Sereda, M. W., Meyer zu Hörste, G., Suter, U., Uzma, N., and Nave, K. A. (2003) Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat. Med. 9, 1533−1537
  7. Slater, H., Bruno, D., Ren, H., La, P., Burgess, T., et al. (2004) Improved testing for CMT1A and HNPP using multiplex ligation-dependent probe amplification (MLPA) with rapid DNA preparations: comparison with the interphase FISH method. Hum. Mutat. 24, 164−171
  8. Szigeti, K., Nelis, E., and Lupski, J. R. (2006) Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies. Neuromolecular Med. 8, 243−254
  9. Verhoeven, K., Villanova, M., Rossi, A., Malandrini, A., De Jonghe, P., et al. (2001) Localization of the gene for the intermediate form of Charcot-Marie-Tooth to chromosome 10q24.1-q25.1. Am. J. Hum. Genet. 69, 889− 894
  10. Chance, P. F., Alderson, M. K., Leppig, K. A., Lensch, M. W., Matsunami, N., et al. (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72, 143−151
  11. Hong, S. H., Nah, H. Y., Lee, Y. J., Lee, J. W., Park, J. H., et al. (2004) Expression of estrogen receptor-alpha and -beta, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodies. Mol. Cells 18, 320−325
  12. Shaw, C. J. and Lupski, J. R. (2005) Non-recurrent 17p11.2 deletions are generated by homologous and non-homologous mechanisms. Hum. Genet. 116, 1−7
  13. Choi, B. O., Lee, M. S., Shin, S. H., Hwang, J. H, Choi, K. G., et al. (2004) Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients. Hum. Mutat. 24, 185−186
  14. Verhoeven, K., Claeys, K. G., Züchner, S., Schroder, J. M., Weis, J., et al. (2006) MFN2 mutation distribution and genotype/ phenotype correlation in Charcot-Marie-Tooth type 2. Brain 129, 2093−2102
  15. Mersiyanova, I. V., Ismailov, S. M., Polyakov, A. V., Dadali, E. L., Fedotov, V. P., et al. (2000) Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients. Hum. Mutat. 15, 340−347
  16. Chung, K. W., Kim, S. B., Park, K. D., Choi, K. G., Lee, J. H., et al. (2006) Early onset severe and late-onset mild Charcot- Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129, 2103−2118
  17. Aarskog, N. K. and Vedeler, C. A. (2000) Real-time quantitative polymerase chain reaction: A new method that detects the peripheral myelin protein 22 duplication in Charcot-Marie- Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum. Genet. 107, 494−498
  18. Palau, F., Löfgren, A., De Jonghe, P., Bort, S., Nelis, E., et al. (1993) Origin of the de novo duplication in Charcot-Marie- Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis. Hum. Mol. Genet. 2, 2031−2035
  19. Patitucci, A., Muglia, M., Magariello, A., Gabriele, A. L., Peluso, G., et al. (2005) Comparison of different techniques for detecting 17p12 duplication in CMT1A. Neuromuscul. Disord. 15, 488−492
  20. Pentao, L., Wise, C. A., Chinault, A. C., Patel, P. I., and Lupski, J. R. (1992) Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat. Genet. 2, 292−300
  21. Latour, P., Boutrand, L., Levy, N., Bernard, R., Boyer, A., et al. (2001) Polymorphic short tandem repeats for diagnosis of the Charcot-Marie-Tooth 1A duplication. Clin. Chem. 47, 829− 837
  22. Badano, J. L., Inoue, K., Katsanis, N., and Lupski, J. R. (2001) New polymorphic short tandem repeats for PCR-based Charcot- Marie-Tooth disease type 1A duplication diagnosis. Clin. Chem. 47, 838−843
  23. Blair, I. P., Nash, J., Gordon, M. J., and Nicholson, G. A. (1996) Prevalence and origin of de novo duplications in Charcot-Marie-Tooth disease type 1A: first report of a de novo duplication with a maternal origin. Am. J. Hum. Genet. 58, 472− 476
  24. LeGuern, E., Gouider, R., Ravise, N., Lopes, J., Tardieu, S., et al. (1996) A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: a new mechanism for deletion in 17p11.2?. Hum. Mol. Genet. 5, 103−106
  25. Young, P., Wiebusch, H., Stogbauer, F., Ringelstein, B., Assmann, G., et al. (1997) A novel frameshift mutation in PMP22 accounts for hereditary neuropathy with liability to pressure palsies. Neurology 48, 450−452
  26. Lupski, J. R., de Oca-Luna, R. M., Slaugenhaupt, S., Pentao, L., Guzzetta, V., et al. (1991) DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66, 219−232
  27. Shaffer, L. G., Kennedy, G. M., Spikes, A. S., and Lupski, J. R. (1997) Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. Am. J. Med. Genet. 69, 325−331
  28. Mariman, E. C., Gabreels-Festen, A. A., Van Beersum, S. E., Valentijn, L. J., Baas, F., et al. (1994) Prevalence of the 1.5- Mb 17p deletion in families with hereditary neuropathy with liability to pressure palsies. Ann. Neurol. 36, 650−655
  29. Matejas, V., Huehne, K., Thiel, C., Sommer, C., Jakubiczka, S., and Rautenstrauss, B. (2006) Identification of Alu elements mediating a partial PMP22 deletion. Neurogenetics 7, 119− 126